Putrajaya has inked a deal to procure an additional 12.2 million doses of COVID-19 vaccine manufactured by Pfizer-BioNTech.

The Health Ministry, in a statement today, said a Manufacturing & Supply Agreement (MSA) was signed by Health Minister Dr Adham Baba, on behalf of the government, via a live conference with Pfizer's country manager (Malaysia and Brunei) Luksanawan Thangpaibool, today

With the purchase, Malaysia will have 25 million doses of Pfizer vaccines, which is enough to cover 39 per cent of its population, the statement added.

The Pfizer vaccine is expected to reach Malaysian shores by the end of February.

The additional procurement of the vaccine, co-developed by US-based Pfizer Inc and German biotechnology firm BioNTech, comes after the National Pharmaceutical Regulatory Agency (NPRA) approved the vaccine recently.

According to reports, a person requires two doses of the vaccination to be protected against COVID-19, which is wreaking havoc on the world.

Pfizer and BioNTech claim that the vaccine is more than 90 per cent effective.

Apart from the two companies, Malaysia also has inked deals with AstraZeneca and Covax Facility, are in final stage of negotiations with Sinovac, CanSino and Gamaleya, to purchase COVID-19 vaccines.

Minister of Science, Technology and Innovation Khairy Jamaluddin had last month said that once the vaccines are procured, about 26.5 million people, or 82.8 per cent of the country's population are expected to be vaccinated for free against COVID-19.

Of late, Malaysia has continuously recorded COVID-19 cases in the four digits.

Yesterday, 2,433 new infections and nine deaths were recorded, bringing the total number of cases and deaths to 135,992 and 551, respectively.

The global infection and death tally from the coronavirus have surpassed 90.6 million, and 1.94 million, respectively.

Source: Malay Mail
Photo source: Astro Awani